We are live on ! Find out more
Gates Foundation

Gates Foundation Portfolio holdings

AUM $43.5M Turnover 0%
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
-13.5%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$3.6M
Cap. Flow
+$23.7M
Cap. Flow %
18.72%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
–
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
LMDX
LumiraDx
LMDX
+$23.7M

Top Sells

Rank Stock Value
1
BCEL
Atreca
BCEL
+$21.5K

Sector Composition

Rank Sector Weight
1 Healthcare 99.29%
2 Materials 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VIR icon
1
Vir Biotechnology
VIR
$1.56B
$30.1M 23.79%
1,559,142
– –
2020 Q4
7 quarters
IMCR icon
2
Immunocore
IMCR
$1.36B
$27.1M 21.42%
576,923
– –
2021 Q1
6 quarters
BNTX icon
3
BioNTech
BNTX
$20.1B
$20.1M 15.89%
148,674
– –
2020 Q4
7 quarters
LMDX
4
DELISTED
LumiraDx
LMDX
$14.6M 11.54%
+14,285,714
New +$23.7M
2022 Q3
0 quarters
CVAC icon
5
DELISTED
CureVac
CVAC
$13.5M 10.67%
1,709,781
– –
2020 Q4
7 quarters
EXAI
6
DELISTED
Exscientia
EXAI
$13.1M 10.36%
1,590,909
– –
2021 Q4
3 quarters
BFLY icon
7
Butterfly Network
BFLY
$1.44B
$4.8M 3.79%
1,011,003
– –
2021 Q1
6 quarters
BCEL
8
DELISTED
Atreca
BCEL
$2.1M 1.66%
1,320,880
-10,478
-0.8% -$21.5K
2020 Q4
7 quarters
AMRS
9
DELISTED
Amyris
AMRS
$900K 0.71%
292,398
– –
2020 Q4
7 quarters
ZY
10
DELISTED
Zymergen
ZY
$200K 0.16%
59,970
– –
2021 Q2
5 quarters

Similar funds

Gates Foundation's Q3 2022 Portfolio in Review

As of Q3 2022, Gates Foundation held 10 positions worth $126M, down 2.8% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation deployed $23.7M of net new capital in Q3 2022, opening 1 new position. Its largest new stake was LumiraDx: 14,285,714 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Materials.

On the sell side, the largest reduction was Atreca, an estimated $21.5K trimmed.

  • Gates Foundation's largest Q3 2022 buy was LumiraDx: 14,285,714 shares worth $14.6M.
  • Gates Foundation's biggest Q3 2022 reduction was Atreca, cutting an estimated $21.5K.
  • Gates Foundation's ten largest holdings make up 100% of its $126M portfolio in Q3 2022.
  • Gates Foundation opened 1 new position and closed 0 in Q3 2022.
  • Gates Foundation's portfolio value fell 2.8% quarter-over-quarter to $126M.

Based on Gates Foundation's 13F filing for Q3 2022, filed 14 Nov 2022.